Literature DB >> 6248284

Production of antibodies to host IgG after transfer of histocompatible cells primed to host allotype.

S A Grace, C J Elson, C M Coeshott.   

Abstract

A method is described to bring about endogenous production of antibodies to the Fc region of IgG. Mice of one allotype (Igb) were immunized against immunoglobulin from a congenic strain of mice bearing another allotype (Iga). The Iga-primed cells were transferred to congenic recipients bearing the Iga allotype and the production of anti-host allotype antibodies by the donor cells measured. Low levels of anti-host allotype antibodies were found in the sera of normal recipients but much greater amounts in recipients pretreated with cyclophosphamide. On ultracentrifugation some of these IgG antibodies sedimented at more than 7S probably because they were complexed with the IgG antigen. It is considered that thismodel may be of use in testing the effect of anti-Fc antibodies on joint inflammation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248284      PMCID: PMC1538080     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  The suppressive effect of carrier priming on the response to a hapten-carrier conjugate.

Authors:  C J Elson; R B Taylor
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

2.  Identification of a gene locus for gamma-G-1 immunoglobulin H chains and its linkage to the H chain chromosome region in the mouse.

Authors:  J D Minna; G M Iverson; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

3.  Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.

Authors:  J L Turk; D Parker; L W Poulter
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

4.  Rheumatoid anti Gm gactors with specificity for the pFc' subfragment of human immunoglobulin G.

Authors:  J B Natvig; M W Turner
Journal:  Nature       Date:  1970-02-28       Impact factor: 49.962

5.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

6.  Hidden rheumatoid factors reacting with "non a" and other antigens of native autologous IgG.

Authors:  P I Gaarder; J B Natvig
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

7.  Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Br Med J       Date:  1975-07-26

8.  Subfragmentation of the Fc fragment of human IgG1 myeloma protein by thermolysin.

Authors:  I M Hunneyball; D R Stanworth
Journal:  Immunology       Date:  1976-04       Impact factor: 7.397

9.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

10.  Quantitative studies of the adoptive immunological memory in mice. I. An age-dependent barrier to syngeneic transplantation.

Authors:  F Celada
Journal:  J Exp Med       Date:  1966-07-01       Impact factor: 14.307

View more
  3 in total

1.  Tolerance to allotypic determinants induced by lymphoid cells from congenic mice bearing the allotype.

Authors:  C J Elson; C M Coeshott
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

2.  Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

Authors:  S A Grace; C J Elson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

3.  Clearance and organ localization of particles and soluble complexes in mice with circulating complexes.

Authors:  S D Carter; F M Brennan; S A Grace; C J Elson
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.